Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 6,084 Reduced 15.21% |
$212,757
$34.97 p/Share
|
Dec 01
2020 |
HCAT
|
Daniel D. Burton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,482 Reduced 2.12% |
$156,780
$34.98 p/Share
|
Dec 01
2020 |
HCAT
|
James Patrick Nelli Jr.
President |
SELL
Open market or private sale
|
Direct | 33,582 Reduced 27.79% |
$1,188,803
$35.4 p/Share
|
Dec 01
2020 |
HCAT
|
James Patrick Nelli Jr.
President |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 14.2% |
$216,000
$10.8 p/Share
|
Dec 01
2020 |
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 11.68% |
$380,765
$35.42 p/Share
|
Dec 01
2020 |
HCAT
|
Paul Horstmeier
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,750 Added 10.46% |
$170,280
$15.84 p/Share
|
Dec 01
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 51.2% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,000 Added 33.86% |
$17,280
$4.32 p/Share
|
Dec 01
2020 |
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.62% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
ADTN
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct | 52 Added 0.21% |
$661
$12.71 p/Share
|
Dec 01
2020 |
ADTN
|
Ronald Centis
SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct | 2 Added 0.01% |
$26
$12.85 p/Share
|
Dec 01
2020 |
ADTN
|
Ray Harris
Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2 Added 0.01% |
$26
$12.85 p/Share
|
Dec 01
2020 |
ADTN
|
Eduard Scheiterer
SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct | 19 Added 0.06% |
$241
$12.71 p/Share
|
Dec 01
2020 |
MGI
|
Chris H. Russell
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,215 Added 50.0% |
-
|
Dec 01
2020 |
MRUS
|
Hui Liu
EVP, CBO & Head of Merus US |
BUY
Exercise of conversion of derivative security
|
Direct | 582 Added 1.0% |
-
|
Dec 01
2020 |
MRUS
|
Lex Bakker
SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 108 Added 2.09% |
-
|
Dec 01
2020 |
MRUS
|
John De Kruif
SVP & Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 79 Added 0.63% |
-
|
Dec 01
2020 |
PBFX
|
Bruce A. Jones |
BUY
Open market or private purchase
|
Direct | 1,000 Added 3.8% |
$9,490
$9.49 p/Share
|
Dec 01
2020 |
IMAX
|
Mark Welton
President IMAX Global Theatres |
SELL
Payment of exercise price or tax liability
|
Direct | 2,784 Reduced 9.7% |
$42,122
$15.13 p/Share
|
Dec 01
2020 |
IMAX
|
Mark Welton
President IMAX Global Theatres |
BUY
Exercise of conversion of derivative security
|
Direct | 5,199 Added 15.34% |
-
|
Dec 01
2020 |
IMAX
|
Kenneth Ian Weissman
Deputy GC, Corp. Sec. & CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 295 Reduced 3.4% |
$4,463
$15.13 p/Share
|
Dec 01
2020 |
IMAX
|
Kenneth Ian Weissman
Deputy GC, Corp. Sec. & CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 867 Added 9.07% |
-
|
Dec 01
2020 |
IMAX
|
Giovanni M. Dolci
Chief Commercial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 230 Reduced 3.68% |
$3,480
$15.13 p/Share
|
Dec 01
2020 |
IMAX
|
Giovanni M. Dolci
Chief Commercial Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct | 484 Added 7.19% |
-
|
Dec 01
2020 |
CRNC
|
Leanne Fitzgerald
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,106 Reduced 2.2% |
$101,464
$91.74 p/Share
|
Dec 01
2020 |
SNDX
|
Michael A Metzger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 45.93% |
$344,550
$22.97 p/Share
|
Dec 01
2020 |
SNDX
|
Michael A Metzger
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 31.47% |
$108,000
$7.2 p/Share
|
Dec 01
2020 |
ACEL
|
Karl Peterson Mr.
Director |
BUY
Other acquisition or disposition
|
Indirect | 46,824 Added 1.44% |
-
|
Dec 01
2020 |
HSKA
|
Kevin S. Wilson
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,631 Reduced 1.98% |
$202,179
$123.96 p/Share
|
Dec 01
2020 |
HSKA
|
Kevin S. Wilson
CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct | 5,625 Added 6.38% |
-
|
Dec 01
2020 |
SSP
|
Mark L Koors
VP/Audit and Compliance |
SELL
Open market or private sale
|
Direct | 11,452 Reduced 22.78% |
$148,876
$13.0 p/Share
|
Dec 01
2020 |
FGEN
|
Mark Eisner
EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,000 Added 50.0% |
-
|
Dec 01
2020 |
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.21% |
$57,816
$26.28 p/Share
|
Dec 01
2020 |
ARQT
|
Howard G. Welgus
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,200 Added 1.19% |
$3,696
$1.68 p/Share
|
Dec 01
2020 |
TNC
|
Chris Killingstad
Director |
SELL
Open market or private sale
|
Direct | 6,592 Reduced 4.22% |
$446,806
$67.78 p/Share
|
Dec 01
2020 |
TNC
|
Chris Killingstad
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 6,592 Added 4.05% |
$265,064
$40.21 p/Share
|
Dec 01
2020 |
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 8,340 Reduced 6.83% |
$98,245
$11.78 p/Share
|
Dec 01
2020 |
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 8,340 Added 6.4% |
$52,709
$6.32 p/Share
|
Dec 01
2020 |
AMWL
|
Keith Anderson
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 17,075 Reduced 1.37% |
$453,171
$26.54 p/Share
|
Dec 01
2020 |
AMWL
|
Kurt Knight
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 17,075 Reduced 1.18% |
$453,171
$26.54 p/Share
|
Dec 01
2020 |
AMWL
|
Bradford Gay
Senior VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 4,037 Reduced 0.49% |
$107,142
$26.54 p/Share
|
Dec 01
2020 |
AMWL
|
Jason Medeiros
Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,457 Reduced 1.43% |
$171,369
$26.54 p/Share
|
Dec 01
2020 |
LMND
|
John Sheldon Peters
Chief Insurance Officer |
SELL
Open market or private sale
|
Direct | 28,800 Reduced 19.65% |
$1,914,624
$66.48 p/Share
|
Dec 01
2020 |
LMND
|
Timothy E Bixby
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,100 Reduced 6.28% |
$1,337,253
$66.53 p/Share
|
Dec 01
2020 |
LMND
|
Daniel A. Schreiber
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 56,650 Reduced 7.32% |
$3,766,092
$66.48 p/Share
|
Dec 01
2020 |
CGC
|
Julious C. Grant Jr
Former Chief Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 26,339 Added 50.0% |
-
|
Dec 01
2020 |
MGNI
|
Adam Lee Soroca
CHIEF PRODUCT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 3,670 Added 1.01% |
$12,662
$3.45 p/Share
|
Dec 01
2020 |
MGNI
|
Adam Lee Soroca
CHIEF PRODUCT OFFICER |
SELL
Open market or private sale
|
Direct | 10,365 Reduced 2.82% |
$201,807
$19.47 p/Share
|
Dec 01
2020 |
UCTT
|
Clarence L Granger
Interim CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 9.59% |
$480,000
$32.0 p/Share
|
Dec 01
2020 |
CASH
|
Michael Robert Kramer
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 29.28% |
$340,200
$34.02 p/Share
|
Dec 01
2020 |